On June 27, 2024, the CDC Director adopted the Advisory Committee on Immunization Practice’s recommendations for use of 2024–2025 COVID-19 vaccines in people ages 6 months and older as approved or authorized by the FDA. The 2024–2025 vaccines are expected to be available in fall 2024. This topic will be updated at that time to align with the new recommendations. Learn more: www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html).

COVID-19 is a disease caused by a virus. Many people who have COVID-19 can have mild symptoms. Other people can have severe illness or die. Older adults or people with certain diseases, such as diabetes, have more risks related to COVID-19 than others.

The best protection against COVID-19 is to take the recommended vaccines. Adults 65 and older who have no immune problems should receive a dose of the 2023-2024 updated COVID-19 vaccine (Pfizer-BioNTech, Moderna, or Novavax), followed by an additional dose at least 4 months later. People who are immunocompromised may require additional vaccine shots and should ask their healthcare professional for guidance.